MedPath

Ephedrine Sulfate

These highlights do not include all the information needed to use EPHEDRINE SULFATE INJECTION safely and effectively. See full prescribing information for EPHEDRINE SULFATE INJECTION. EPHEDRINE SULFATE injection, for intravenous use Initial U.S. Approval: 2016

Approved
Approval ID

d89dd8d5-7698-61db-e053-2a95a90a764b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 3, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ephedrine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7276
Application NumberANDA214579
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ephedrine Sulfate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 3, 2023
FDA Product Classification

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EPHEDRINE SULFATEActive
Quantity: 50 mg in 1 mL
Code: U6X61U5ZEG
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ephedrine Sulfate - FDA Drug Approval Details